The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Sachsen-Anhalt; Sachsen-Anhalt; Halle (Saale), Kreisfreie Stadt
Location of affected unit(s)
Halle
Sector
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 20 - Manufacture of chemicals and chemical products 20 - Manufacture of chemicals and chemical products
100 jobs Number of planned job creations
Announcement Date
3 June 2024
Employment effect (start)
3 June 2024
Foreseen end date
3 June 2024
Description
The German chemical company Wacker Biotech, a subsidiary of Wacker Chemie, has officially opened a new mRNA competence centre at its site in Halle (Saale), Saxony-Anhalt, creating 100 new jobs.
The background to this is the construction of a new mRNA competence centre, in which the company has invested over €100 million. The new facility can produce active ingredients based on messenger ribonucleic acid (mRNA) on a large scale. Over 100 highly qualified jobs are created at the centre as a result.
Wacker Chemie has around 16,400 employees at 27 production sites and 48 sales offices worldwide and annual sales of around €6.40 billion in 2023. In 2023, Wacker has also created 100 new jobs in Bavaria Wacker Chemie - 2023 - DE.
Sources
3 June 2024: Wacker Chemie Press release (www.wacker.com)
5 July 2022: Wacker Chemie Press release (www.wacker.com)
Citation
Eurofound (2024), Wacker Biotech, Business expansion in Germany, factsheet number 201271, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/201271.